204 Combining FT536, a pan-tumor targeting CAR NK cell therapy, with CD16 engagers provides a coordinated targeting strategy to overcome tumor heterogeneity
Regular and Young Investigator Award Abstracts（2022）
关键词
car nk cell therapy,ft536,cd16 engagers,pan-tumor heterogeneity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要